Frontiers in Pharmacology | Neuropharmacology

Brief Research Report

Published on 30 Oct 2024

Increased functional connectivity between brain regions involved in social cognition, emotion and affective-value in psychedelic states induced by N,N-Dimethyltryptamine (DMT)

in Neuropharmacology

Carla Soares
Gisela Lima
Marta Lapo Pais
Marta Teixeira
Célia Cabral
Miguel Castelo-Branco

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1454628

2,699 views
2 citations

Original Research

Published on 28 Oct 2024

Patients with dementia: prevalence and type of drug–drug interactions

in Neuropharmacology

María Cristina Muñoz-Contreras
Begoña Cerdá
Francisco Javier López-Román
Ignacio Segarra

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1472932

1,358 views
1 citation

Mini Review

Published on 28 Oct 2024

The impacts of tobacco and nicotine on HIV-1 infection, inflammation, and the blood-brain barrier in the central nervous system

in Neuropharmacology

Aislinn M. Keane
Talia H. Swartz

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1477845

1,549 views
2 citations

Original Research

Published on 25 Oct 2024

Dopamine internalization via Uptake2 and stimulation of intracellular D5-receptor-dependent calcium mobilization and CDP-diacylglycerol signaling

in Neuropharmacology

Wenfei Kang
Arlette Deukam Siewe
Chizurum C. Oluigbo
Mercy O. Arijesudade
Eugen Brailoiu
Ashiwel S. Undieh

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1422998

1,444 views

Systematic Review

Published on 23 Oct 2024

Stem cell-derived exosomes for ischemic stroke: a conventional and network meta-analysis based on animal models

in Neuropharmacology

Kangli Xu
Xiaohui Zhao
Yuxuan He
Hongxin Guo
Yunke Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1481617

3,678 views
2 citations

Original Research

Published on 22 Oct 2024

Green rush and red warnings: Retrospective chart review of adverse events of interactions between cannabinoids and psychotropic drugs

in Neuropharmacology

Adrian Andrzej Chrobak
Jarosław Woroń
Marcin Siwek

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1500312

2,571 views
1 citation

Original Research

Published on 17 Oct 2024

Precuneal hyperperfusion in patients with attention-deficit/hyperactivity disorder-comorbid nociplastic pain

in Neuropharmacology

Miwako Takahashi
Satoshi Kasahara
Tsutomu Soma
Taito Morita
Naoko Sato
Ko Matsudaira
Shin-Ichi Niwa
Toshimitsu Momose

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1480546

3,049 views
3 citations

Systematic Review

Published on 17 Oct 2024

The effects of standardized cannabis products in healthy volunteers and patients: a systematic literature review

in Neuropharmacology

Nadia A. Leen
Mikael A. Kowal
Albert Batalla
Matthijs G. Bossong

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1411631

2,975 views

Review

Published on 17 Oct 2024

The role of exercise-related FNDC5/irisin in depression

in Neuropharmacology

Yaqi Liu
Xiying Fu
Xing Zhao
Ranji Cui
Wei Yang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1461995

2,723 views
4 citations

Original Research

Published on 16 Oct 2024

Decreasing brain activity caused by acute administration of ketamine and alcohol – A randomized, controlled, observer-blinded experimental study

in Neuropharmacology

Luan Oliveira Ferreira
Esther Padilha da Silveira
Clarissa A. Paz
Maria K. Otake Hamoy
Gabriela B. Barbosa
Murilo F. Santos
Raína M. Conceição
Anthony Lucas G. Amaral
Karina Dias Resende
Dielly Catrina Favacho Lopes

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1456009

1,019 views

Editorial

Published on 14 Oct 2024

Editorial: New players on the monoaminergic field: relevance to the mental disorders

in Neuropharmacology

Eliyahu Dremencov
Daniela Jezova

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1504261

755 views

Original Research

Published on 14 Oct 2024

Identification and experimental validation of hub genes underlying depressive-like behaviors induced by chronic social defeat stress

in Neuropharmacology

Yexiang Chen
Yunhao Jiang
Xingcong Jiang
Caiyu Zhai
Yifei Wang
Chi Xu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1472468

1,250 views

Brief Research Report

Published on 10 Oct 2024

Chronic exposure to inhaled vaporized cannabis high in Δ9-THC suppresses Adderall-induced brain activity

in Neuropharmacology

Jack M. Ognibene
Rajeev I. Desai
Praveen P. Kulkarni
Craig F. Ferris

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1413812

4,790 views

Original Research

Published on 09 Oct 2024

Fentanyl enhances immune cell response through TLR4/MD-2 complex

in Neuropharmacology

Chiara Chemello
Laura Facci
Emma Marcolin
Giovanni Eugenio Ramaschi
Massimo Barbierato
Pietro Giusti
Chiara Bolego
Morena Zusso

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1468644

1,662 views

Original Research

Published on 07 Oct 2024

Inhibition of HCN1 currents by norquetiapine, an active metabolite of the atypical anti-psychotic drug quetiapine

in Neuropharmacology

Amélie Jean Jacques
Nazzareno D’Avanzo

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1445509

1,318 views

Editorial

Published on 03 Oct 2024

Editorial: Reviews in neuropharmacology 2023: microbiota gut-brain axis, therapeutic insights for neurodegenerative diseases

in Neuropharmacology

Bhagavathi Sundaram Sivamaruthi
Natarajan Suganthy
Carolina Pellegrini

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1499072

914 views